Does Public Reporting of Cost or Resource Use Measures for a Consumer Audience Make Sense? Ateev Mehrotra, MD, MPH University of Pittsburgh School of Medicine.

Slides:



Advertisements
Similar presentations
Nursing Diagnosis: Definition
Advertisements

THE ACUTE NEED FOR DELIVERY SYSTEM REFORM MARGARET E. OKANE.
The Impact of Retail Clinics on Quality, Access, and Costs Ateev Mehrotra, MD, MPH University of Pittsburgh School of Medicine RAND Health.
PAYING FOR PERFORMANCE In PUBLIC HEALTH: Opportunities and Obstacles Glen P. Mays, Ph.D., M.P.H. Department of Health Policy and Administration UAMS College.
Who Can Use MONAHRQ? May 2014 Note: This is one of seven slide sets outlining MONAHRQ and its value, available at
Hospital Volume and 30-day Mortality following Hospitalization for Acute Myocardial Infarction and Heart Failure Joseph S. Ross, MD, MHS Mount Sinai School.
Introduction to the User’s Guide for Developing a Protocol for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research.
MEDICINES SELECTION & FORMULARY MANAGEMENT
Stephen N. Flood New Orange Hills, Inc. Orange, CA.
The Liverpool Care Pathway Dr Kate Tredgett, Consultant in Palliative Medicine.
Value-based Care Strategies in Utah: Paying for Better Health Outcomes Governor’s 2014 Health Summit Afternoon Breakout Session September 30, 2014.
SEBs: “What do patients say? Presented by Cheryl L. Koehn 2015 CADTH Symposium Saskatoon, Saskatchewan April 14, 2015.
Lecture 9 Tuesday, October 2 Healthcare and the Market.
Grinols and Mustard Impact of a casino opening on crime rates Concern: casinos are not random – opened in struggling areas Data at county/year level –
Step 3 : Analyze nursing diagnoses relationships  Draw lines between nursing diagnoses to indicate relationships.  Prepared to verbally explain to your.
Presentation by Bill Barcellona Sr. V. P
Value & Coverage Issue Brief Slides A Closer Look at Evidence-Based Performance Measurement.
1 Quality of Health Care in the U.S.: How Good Is It & What Have We Learned About How to Improve It? Stephanie Teleki, Ph.D. Cheryl Damberg, Ph.D. Robert.
Paying Less By Purchasing Smarter Gerard Anderson, PhD Professor Johns Hopkins University.
Demand for Health Care Purpose of demand analysis for health care is to determine those factors that on average most effect utilization of medical services.
1 Health Cost Control Payment Reform and Health Cost Control in Massachusetts Fall 2009.
Developing a Playbook for Payment Reform Robert S. Galvin, MD 4 th National Pay for Performance Summit March 10, 2009.
Health Care Reform Cost Savings Julie Sonier Director, Health Economics Program Minnesota Department of Health SCI Summer Meeting July 31, 2008.
Robert Margolis, M.D. Chairman & CEO HealthCare Partners ACO’s – Getting from Here to There Benefits / Risks / Opportunities.
Slides for Class 2 H ADM 545 January 17, Broad model depicting what a Health Care Organizations (HCO) must do to remain financially viable. Hire.
AHRQ’s Role in Comparative Effectiveness Carolyn M. Clancy, MD Director Agency for Healthcare Research and Quality Alliance for Health Reform Briefing.
Overview Public Reporting Cardiovascular Data Recommendations.
Paying for Quality Health Care: States’ Roles  March 24, 2011  New Hampshire General Court  Concord NH  Ellen Andrews, PhD  Health Policy Consultant.
© 2010 Cengage Learning. All Rights Reserved. May not be scanned, copied or duplicated, or posted to a publicly accessible website, in whole or in part.
Reduction Of Hospital Readmissions Hany Salama, MD Diplomat ABIM IM Hospice and Palliative Care Sleep Medicine.
Chartered Value Exchanges (CVEs) September 2008 CVEs may wish to tailor this slide deck for use with stakeholders in your community.
Nursing Excellence Conference April 19,2013
Employer Payment Reform Workshop I January 11, 2013 Supported by Robert Wood Johnson Foundation’s Aligning Forces for Quality The Call to Action; If Not.
Role of Consumers U.S. Health Care System. Perfect competition assumes consumers and producers have perfect information. What’s so good about perfect.
Health Care Distribution, Ch. 7. United States Gross Domestic Product (GDP) in 2002 was 10 trillion dollars  1.6 trillion of it was spent on health care.
Crossing the Quality Chasm: The Role of Information Technology Janet M. Corrigan, PhD, MBA Institute of Medicine.
Considerations in Public Reporting of the AHRQ QIs Shoshanna Sofaer, Dr.P.H. School of Public Affairs Baruch College.
IDENTIFYING KEY AREAS FOR DELIVERY SYSTEM RESEARCH The Challenge and Promise of Delivery System Research: A Meeting of AHRQ Grantees, Experts and Stakeholders.
Investing in Children’s Health Care Quality Improvement: Returns in Lives, Health, and Dollars—An Illustration Denise Dougherty, Ph.D., Presented by Anne.
Why Use MONAHRQ for Health Care Reporting? March 2015 Note: This is one of eight slide sets outlining MONAHRQ and its value, available at
Standard 9. Evidence-based Practice and Research
Refining Key Questions: Interactive Case Study Quiz C. Michael White, PharmD, FCP, FCCP Professor and Director University of Connecticut / Hartford Hospital.
Pay for Performance in BCBS Plans Nationally June 22, 2005 National Press Club Bruce E. Landon, M.D., M.B.A.
Robert S. Galvin, MD Medicare Prescription Drug Congress February 26, 2004 Medicare Prescription Drugs Improvement and Modernization Act of 2003: What.
THE HIT ADOPTIONINITIATIVE The George Washington University School of Public Health and Health Services The Institute for Health Policy at MGH/Partners.
Standard 15. Resource Utilization The registered nurse utilizes appropriate resources to plan and provide nursing services that are safe, effective and.
A Journey Together: New Maryland Healthcare Landscape Baltimore County Forum Maryland Health Services Cost Review Commission June 2015.
Class 8: Challenging assumptions that support demand theory; how skepticism regarding these assumptions are fueling the current health policy debate at.
Improving Patient-Centered Care in Maryland—Hospital Global Budgets
Community Paramedic Payment Reform December 2 nd,2015 Terrace Mall- North Memorial.
Milliman & Robertson, Inc. INTERNATIONALLY Woodrow Milliman 1 Casualty Actuarial Society 1999 Special Interest Seminar Health and Managed Care October.
A NEW REIMBURSEMENT STRUCTURE FOR AMERICA ADVANCED DISEASE CONCEPTS.
Helen Burstin, MD, MPH Director, Center for Primary Care Research Agency for Healthcare Research and Quality April 16, 2001 The Effect of Working Conditions.
Thomas B. Valuck, MD, JD Medical Officer & Senior Adviser Center for Medicare Management Centers for Medicare & Medicaid Services CMS’ Progress Toward.
Where Are We Going? Are We All Rowing In the Same Direction? Peter Rutherford, MD.
THE HEALTHCARE ENVIRONMENT MERGERS AND CONSOLIDATION William S. Custer, Ph.D. April14, 2016.
CIS 170 MART Teaching Effectively/cis170mart.com FOR MORE CLASSES VISIT HCA 375 CART Inspiring Minds/hca375cart.com FOR MORE CLASSES.
Understanding Community Cancer Care.  Historically, cancer care occurred predominantly in hospital setting  A few decades ago, care migrated to the.
Chapter 3 An Overview of the Healthcare Financing System Copyright 2015 Health Administration Press1.
A POCKET GUIDE TO PUBLIC SPEAKING 4 TH EDITION Chapter 36 Nursing and Allied Health Courses.
Beyond Measurement: Considerations for P4P
Thomas B. Valuck, MD, JD Medical Officer & Senior Adviser
Health Strategies Group
Investments in Primary Care
Implementing the IOM’s Rewarding Provider Performance Report
Module 4 Part 2 Selecting Measures
Organization as an Enabler of High Performance
Delivering Care at Home for Medicare Advantage Enrollees
Presentation transcript:

Does Public Reporting of Cost or Resource Use Measures for a Consumer Audience Make Sense? Ateev Mehrotra, MD, MPH University of Pittsburgh School of Medicine RAND Health

Outline 1. Current landscape of measures 2. Concerns with current model 3. Suggestions for improvement

New Jersey Hospital Price Compare

Medicare Hospital Compare

Florida Agency for Health Care Administration. Nursing Home Guide

What is a Cost or Resource Use Measure? Terminology can be confusing Resource use, value, relative costs, efficiency “Efficiency” per IOM is a quality domain Distinction b’ween cost & efficiency/value Costs for a given outcome Health outcomes per dollar Cost & Resource Use Measures PMPM / patient per year Per episode costs Per hospitalization costs Utilization measures – generic prescribing Overuse measures Price transparency – daily price of nursing home

Selection Model Berwick et al, 2003, Medical Care Selection of Providers

Concerns with Selection Pathway 1. Consumers typically immune to costs 2. Higher costs = higher quality 3. Lack of trust and understanding 4. Not relevant to decisions actually made Our view is that in their current form and absent any financial incentives, publicly reporting of cost measures is unlikely to lead to the hoped for consumer response.

Quality of care for deliveries How much you will pay out of your own pocket? HIGH QUALITY HOSPITALS AT A REASONABLE PRICE Hospital A$100 Hospital B $100 Hospital C $100 OTHER HOSPITALS Hospital J$250 Hospital K $250 Hospital L $250 Click here for details on how quality measured Click here for how we decide on out of pocket costs Making Selection Pathway More Viable Improvements - Relevant choices - Less is more - Link to quality - Link out of pocket $$ - More information - Test, test, test

Quality of care for deliveries How much you will pay out of your own pocket? HIGH QUALITY HOSPITALS AT A REASONABLE PRICE Hospital A$100 Hospital B $100 Hospital C $100 OTHER HOSPITALS Hospital J$250 Hospital K $250 Hospital L $250 Click here for details on how quality measured Click here for how we decide on out of pocket costs Making Selection Pathway More Viable Improvements - Relevant choices - Less is more - Link quality, not value - Link out of pocket $$ - More information - Test, test, test

Quality of care for deliveries How much you will pay out of your own pocket? HIGH QUALITY HOSPITALS AT A REASONABLE PRICE Hospital A$100 Hospital B $100 Hospital C $100 OTHER HOSPITALS Hospital J$250 Hospital K $250 Hospital L $250 Click here for details on how quality measured Click here for how we decide on out of pocket costs Making Selection Pathway More Viable Improvements - Relevant choices - Less is more - Link quality, not value - Link out of pocket $$ - More information - Test, test, test

Quality of care for deliveries How much you will pay out of your own pocket? HIGH QUALITY HOSPITALS AT A REASONABLE PRICE Hospital A$100 Hospital B $100 Hospital C $100 OTHER HOSPITALS Hospital J$250 Hospital K $250 Hospital L $250 Click here for details on how quality measured Click here for how we decide on out of pocket costs Making Selection Pathway More Viable Improvements - Relevant choices - Less is more - Link quality, not value - Link out of pocket $$ - More information - Test, test, test

Quality of care for deliveries How much you will pay out of your own pocket? HIGH QUALITY HOSPITALS AT A REASONABLE PRICE Hospital A$100 Hospital B $100 Hospital C $100 OTHER HOSPITALS Hospital J$250 Hospital K $250 Hospital L $250 Click here for details on how quality measured Click here for how we decide on out of pocket costs Making Selection Pathway More Viable Improvements - Relevant choices - Less is more - Link quality, not value - Link out of pocket $$ - More information - Test, test, test

Quality of care for deliveries How much you will pay out of your own pocket? HIGH QUALITY HOSPITALS AT A REASONABLE PRICE Hospital A$100 Hospital B $100 Hospital C $100 OTHER HOSPITALS Hospital J$250 Hospital K $250 Hospital L $250 Click here for details on how quality measured Click here for how we decide on out of pocket costs Making Selection Pathway More Viable Improvements - Relevant choices - Less is more - Link quality, not value - Link out of pocket $$ - More information - Test, test, test

Quality of care for deliveries How much you will pay out of your own pocket? HIGH QUALITY HOSPITALS AT A REASONABLE PRICE Hospital A$100 Hospital B $100 Hospital C $100 OTHER HOSPITALS Hospital J$250 Hospital K $250 Hospital L $250 Click here for details on how quality measured Click here for how we decide on out of pocket costs Improvements - Relevant choices - Less is more - Link quality, not value - Link out of pocket $$ - More information - Test, test, test Making Selection Pathway More Viable

Do Consumer Need to Respond? Reputation

Higher than Average Rehospitalizations Hospital A 13.1% Hospital B 12.2% Hospital C 12.1% Hospital D 9.2% Hospital E 8.3% Average Hospital 4.1% Care for Myocardial Infarction Key points - Focus on reputation - Choice not patient relevant - More complex data - Focus on high cost providers Making Reputation Pathway More Viable

Key points - Focus on reputation - Choice not patient relevant - More complex data - Focus on high cost providers Higher than Average Rehospitalizations Hospital A 13.1% Hospital B 12.2% Hospital C 12.1% Hospital D 9.2% Hospital E 8.3% Average Hospital 4.1% Making Reputation Pathway More Viable Infarction

Higher than Average Rehospitalizations Hospital A 13.1% Hospital B 12.2% Hospital C 12.1% Hospital D 9.2% Hospital E 8.3% Average Hospital 4.1% Making Reputation Pathway More Viable Care for Myocardial Infarction Key points - Focus on reputation - Choice not patient relevant - More complex data - Focus on high cost providers

Higher than Average Rehospitalizations Hospital A 13.1% Hospital B 12.2% Hospital C 12.1% Hospital D 9.2% Hospital E 8.3% Average Hospital 4.1% Making Reputation Pathway More Viable Care for Myocardial Infarction Key points - Focus on reputation - Choice not patient relevant - More complex data - Focus on high cost providers

Higher than Average Rehospitalizations Hospital A 13.1% Hospital B 12.2% Hospital C 12.1% Hospital D 9.2% Hospital E 8.3% Average Hospital 4.1% Making Reputation Pathway More Viable Care for Myocardial Infarction Key points - Focus on reputation - Choice not patient relevant - More complex data - Focus only on high cost providers

Key Take Aways In current form cost measures unlikely to have the desired impact Consider which pathway on which to focus –Impacts presentation, choice of measures, link to quality, and financial incentives Limited scientific evidence base on consumer response

Acknowledgements Co-authors –Judy Hibbard –Arnie Milstein –Peter Hussey Paper written for AHRQ National Summit on Public Reporting for Consumers Questions –Ateev Mehrotra